VH “heavy chains” (portion of antibody molecules) produced by genetically engineered Escherichia coli cells that act to bind antigens in a manner similar to antibodies or monoclonal antibodies (MAbs). Similar to MAbs, dAbs can be produced in large quantities, to be used as human or animal therapeutics (e.g., to combat diseases).